RxDoctor Payments Data

Natausha Smith

Psychiatric/Mental Health · Kennett, MONPI 1912771056

Payments from drug & device makers

$1,420in general payments, 2019–2025

Across 73 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$245
  • Neurocrine Biosciences, Inc.$222
  • E.r. Squibb & Sons, L.L.C.$172
  • Lundbeck LLC$158
  • Johnson & Johnson$138
  • Otsuka America Pharmaceutical, Inc.$122
  • plus $362 from 5 others

What the payments were for

  • Food & beverage$1,420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,420 in reported general payments places this provider in the 60th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$7,450
Medicare patients
30
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate16$45,462
Abilify MaintenaAripiprazole11$31,182
Lurasidone Hcl26$8,291
Chlorpromazine Hcl28$2,974
Doxepin Hcl131$2,746
Oxcarbazepine48$1,622
Vilazodone Hcl21$997
Quetiapine Fumarate105$974
Duloxetine Hcl48$949
Buspirone Hcl78$857
Carbamazepine ErCarbamazepine13$788
Aripiprazole34$626
Bupropion XlBupropion Hcl18$513
Hydroxyzine Hcl37$470
Venlafaxine Hcl ErVenlafaxine Hcl55$442

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$138$45,46216 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$122$31,18211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Kennett

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →